Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-35
Closed -$2K 459
2020
Q3
$2K Hold
35
﹤0.01% 826
2020
Q2
$2K Hold
35
﹤0.01% 795
2020
Q1
$1K Hold
35
﹤0.01% 778
2019
Q4
$2K Hold
35
﹤0.01% 743
2019
Q3
$2K Hold
35
﹤0.01% 727
2019
Q2
$2K Hold
35
﹤0.01% 716
2019
Q1
$2K Buy
+35
New +$1.58K ﹤0.01% 1321

Other funds holding HOLX

Weaver Consulting Group's HOLX Position: Q4 2020 in Review

Weaver Consulting Group sold out of Hologic (HOLX) in Q4 2020, closing a stake of 35 shares — an estimated $2K sold.

Weaver Consulting Group first reported a position in HOLX in Q1 2019 and held it in 7 quarters. The position peaked at $2K in Q3 2020. 628 funds tracked by Wall St. Rank hold HOLX as of Q4 2020.

  • Weaver Consulting Group reported no remaining Hologic position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 35 Hologic shares in Q4 2020, an estimated $2K.
  • Weaver Consulting Group first reported a position in Hologic in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Hologic position peaked at $2K in Q3 2020.
  • 628 funds tracked by Wall St. Rank held Hologic as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.